EXEL
Exelixis Inc
Price:  
41.53 
USD
Volume:  
1,762,430.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXEL EV/EBITDA

8.9%
Upside

As of 2026-03-29, the EV/EBITDA ratio of Exelixis Inc (EXEL) is 11.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EXEL's latest enterprise value is 10,303.27 mil USD. EXEL's TTM EBITDA according to its financial statements is 921.56 mil USD. Dividing these 2 quantities gives us the above EXEL EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.4x - 14.7x 12.6x
Forward P/E multiples 9.6x - 13.6x 11.6x
Fair Price 36.86 - 54.02 45.23
Upside -11.2% - 30.1% 8.9%
41.53 USD
Stock Price
45.23 USD
Fair Price

EXEL EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-03-27 11.18
2026-03-26 11.41
2026-03-25 11.53
2026-03-24 11.19
2026-03-23 11.15
2026-03-20 11.11
2026-03-19 11.10
2026-03-18 11.10
2026-03-17 11.26
2026-03-16 11.05
2026-03-13 11.10
2026-03-12 11.08
2026-03-11 11.24
2026-03-10 11.11
2026-03-09 11.42
2026-03-06 11.18
2026-03-05 11.11
2026-03-04 11.23
2026-03-03 10.96
2026-03-02 11.04
2026-02-27 11.89
2026-02-26 11.96
2026-02-25 12.09
2026-02-24 12.20
2026-02-23 11.88
2026-02-20 11.77
2026-02-19 11.92
2026-02-18 12.01
2026-02-17 11.90
2026-02-13 11.85
2026-02-12 11.51
2026-02-11 11.58
2026-02-10 11.59
2026-02-09 11.86
2026-02-06 11.85
2026-02-05 11.42
2026-02-04 11.50
2026-02-03 11.48
2026-02-02 11.54
2026-01-30 11.13
2026-01-29 11.39
2026-01-28 11.50
2026-01-27 11.80
2026-01-26 11.77
2026-01-23 11.95
2026-01-22 12.02
2026-01-21 12.10
2026-01-20 11.81
2026-01-16 11.87
2026-01-15 12.28